Miscellaneous Quiz / Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

Forced Order
Also try: Candy Bars!!!
Challenge
Share
Tweet
Embed
Score 0/96 Timer 20:00
HintAnswer
Risperidone class
Use: alleviation of chorea
P-kinetics: Similar to Pramipexole
Olanzapine class
Benzotropine class
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
Fluphenzaine class
Use: prolong ALS survival by months
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
P-kinetics: Start at low dose & gradually increase
Pramipexole class
MOA: Central (brain) anti-cholinergic
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
TCA class
P-kinetics: Start with a small dose
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Tetrabenxine class
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Rasagiline class
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
Haloperidol class
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Clonidine class
Riluzole class
HintAnswer
Selegiline class
MOA: D2 receptor agonist (partial D1 agonist)
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Bromocriptine class
Phenothiazine class
Use: depression associated with Huntington's disease
Tolcapone class
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
Carbidopa class
Orphenadrine class
Amantadine class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Carbidopa + levidopa (1:10 or 1:4)
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Quetiapine class
Pergolide class
Carbamazepine class
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Ropinirole class
Use: Similar to Pramipexole
Procyclidine class
Reserpine class
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
HintAnswer
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
P-kinetics: Given PO. Loses effectiveness over time.
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Entacapone class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
SSRI class
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Biperiden class
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
Apomorphine class
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
Clonazepam class
Use: Most effective drug in tx of Tourette's
Levodopa class
Use: alleviation of chorea if refractory to atypical
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
SE: Insomnia when taken late in the day
MOA: D1 and D2 receptor agonist
Use: Gold standard in Parkinson's dz - most efficacious treatment
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
MOA: Pure D2 receptor agonist
MOA: Preferential affinity for D3 family of receptors
Butyrophenones class
Trihexyphenidyl class
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.